NYSE · CIK 0001395064
TAK TAKEDA PHARMACEUTICAL CO LTD
Insider trading from SEC Form 4. Last filing 28 d ago. Close $18.73 on Oct 9, 2026, +42% from the 52-week low and -2% from the high.
In brief
TAKEDA PHARMACEUTICAL CO LTD (TAK) has 52 SEC Form 4 filings on file from 24 insiders, the latest filed on Sep 15, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 19 open-market sells worth $13M, net -$13M.
19 open-market trades have been scored at TAK. The newest: Lauren Rusckowski Duprey (Chief Transformation Officer) sold $640k of stock on Sep 14, 2026, filed Sep 15, 2026, scored 48 (moderate). The largest of the 19 shown: Andrew Stewart Plump (President, R&D) sold $2.8M on Aug 10, 2026, scored 65 (notable). 2 insiders sold within 14 days of each other around Sep 14, 2026.
25 Form 144 notices of planned sales are on file, the latest filed Sep 10, 2026.
Last 90 days
Net insider value
-$13M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
19
$13M by 13 insiders
Insiders on file
24
with a Form 4 at this company
Price and insider trades, last year
TAKOct 9, 2026 · close 18.73
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at TAKEDA PHARMACEUTICAL CO LTD, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Lauren Rusckowski Duprey Chief Transformation Officer sell | $640k 34,535 shares | -15% | - | |
| 43Moderate | Andrew Stewart Plump President, R&D sell | $2.1M 116,191 shares | -44% | +39% from low-2% from high | |
| 30Weak | Andrew Stewart Plump President, R&D sell | $363k 19,651 shares | -7% | +39% from low-2% from high | |
| 48Moderate | Nicola Deidre Petal Greenway Chief Human Resources Officer sell | $235k 12,980 shares | -24% | +36% from low-4% from high | |
| 63Notable | Teresa Marie Bitetti President, OBU sell | $855k 50,012 shares | -17% | +33% from low-7% from high | |
| 57Moderate | Lauren Rusckowski Duprey Chief Transformation Officer sell | $814k 47,586 shares | -17% | +33% from low-7% from high | |
| 48Moderate | Awny Samaan Botros Farajallah Chief Medical Officer sell | $240k 14,006 shares | -11% | +33% from low-7% from high | |
| 53Moderate | Natalie Anne Marie Furney Global General Counsel sell | $528k 30,868 shares | -13% | +33% from low-7% from high | |
| 59Moderate | Nicola Deidre Petal Greenway Chief Human Resources Officer sell | $606k 34,603 shares | -37% | +33% from low-7% from high | |
| 45Moderate | Nicola Deidre Petal Greenway Chief Human Resources Officer sell | $116k 6,774 shares | -11% | +33% from low-7% from high | |
| 45Moderate | Ramy Riad Ahmed Ibrahim President, PDT BU sell | $124k 7,277 shares | -7% | +33% from low-7% from high | |
| 70Notable | Julie So-Young Kim President and CEO sell | $1.5M 89,090 shares | -19% | +33% from low-7% from high | |
| 49Moderate | Rhonda Janice Pacheco President, U.S. Business Unit sell | $289k 16,901 shares | -8% | +33% from low-7% from high | |
| 51Moderate | Agosti Marcello Pignagnoli Head, Strat. & Port. Dev sell | $393k 22,957 shares | -11% | +33% from low-7% from high | |
| 53Moderate | Giles Richard Platford President, IBU sell | $532k 31,083 shares | -9% | +33% from low-7% from high | |
| 65Notable | Andrew Stewart Plump President, R&D sell | $2.8M 165,393 shares | -18% | +33% from low-7% from high | |
| 52Moderate | Gabriele Ricci Chief Data & Tech. Officer sell | $429k 25,088 shares | -13% | +33% from low-7% from high | |
| 50Moderate | Elaine Mary Shannon Pres., Global Supply & Quality sell | $357k 20,363 shares | -23% | +32% from low-7% from high | |
| 38Weak | Elaine Mary Shannon Pres., Global Supply & Quality sell | $68k 3,978 shares | -6% | +33% from low-7% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 10, 2026 | Lauren Rusckowski Duprey Chief Transformation Officer | 34,535 0.02% of outstanding | $634k | Sep 10, 2026 | $814k |
| Sep 2, 2026 | Plump Andrew Stewart Officer | 116,191 0.01% of outstanding | $2.1M | Sep 2, 2026 | $363k |
| Aug 19, 2026 | Plump Andrew Stewart Officer | 19,651 0.00% of outstanding | $363k | Aug 19, 2026 | none |
| Aug 14, 2026 | Nicola Greenway Chief Human Resources Officer | 12,980 0.01% of outstanding | $226k | Aug 14, 2026 | $721k |
| Aug 10, 2026 | Elaine Shannon President, Global Supply & Quality | 20,363 0.01% of outstanding | $355k | Aug 11, 2026 | $72k |
| Aug 6, 2026 | Nicola Greenway Chief Human Resources Officer | 34,603 0.02% of outstanding | $579k | Aug 7, 2026 | $123k |
| Jul 13, 2026 | Teresa Bitetti President, Global Oncology Business Unit | 54,210 0.04% of outstanding | $908k | Jul 13, 2026 | none |
| Jul 13, 2026 | Lauren Rusckowski Duprey Chief Transformation Officer | 51,579 0.04% of outstanding | $864k | Jul 13, 2026 | none |
| Jul 13, 2026 | Awny Farajallah Chief Medical Officer | 15,188 0.01% of outstanding | $254k | Jul 13, 2026 | none |
| Jul 13, 2026 | Natalie Furney Global General Counsel | 33,454 0.02% of outstanding | $560k | Jul 13, 2026 | none |
| Jul 13, 2026 | Nicola Greenway Chief Human Resources Officer | 7,348 0.01% of outstanding | $123k | Jul 13, 2026 | none |
| Jul 13, 2026 | Ramy Riad President, Plasma-Derived Therapies Business Unit | 7,889 0.01% of outstanding | $132k | Jul 13, 2026 | none |
| Jul 13, 2026 | Julie Kim President and CEO | 96,558 0.07% of outstanding | $1.6M | Jul 13, 2026 | none |
| Jul 13, 2026 | Rhonda Pacheco President, US Business Unit and US Country Head | 18,316 0.01% of outstanding | $307k | Jul 13, 2026 | none |
| Jul 13, 2026 | Marcello Pignagnoli Agosti Interim Head, Strategy and Portfolio Development | 24,887 0.02% of outstanding | $417k | Jul 13, 2026 | none |
| Jul 13, 2026 | Giles Platford President, International Business Unit | 33,696 0.02% of outstanding | $564k | Jul 13, 2026 | none |
| Jul 13, 2026 | Andrew Plump President, Research & Development | 179,239 0.13% of outstanding | $3.0M | Jul 13, 2026 | none |
| Jul 13, 2026 | Gabriele Ricci Chief Data & Technology Officer | 27,197 0.02% of outstanding | $456k | Jul 13, 2026 | none |
| Jul 13, 2026 | Elaine Shannon President, Global Supply & Quality | 4,319 0.00% of outstanding | $72k | Jul 13, 2026 | none |
| Dec 9, 2025 | Lauren Rusckowski Duprey Chief Human Resources Officer | 29,619 0.02% of outstanding | $421k | Dec 9, 2025 | none |
| Dec 5, 2025 | Teresa Marie Bitetti President, Global Oncology Business Unit | 87,023 0.07% of outstanding | $1.2M | Dec 5, 2025 | none |
| Dec 4, 2025 | Giles Richard Platford President, Plasma-Derived Therapies Business Unit | 58,421 0.05% of outstanding | $836k | Dec 4, 2025 | none |
| Jul 9, 2025 | Akiko Amakawa Corporate Strategy Officer & CEO Chief of Staff | 5,608 0.00% of outstanding | $86k | Jul 9, 2025 | none |
| Jul 9, 2025 | Teresa Marie Bitetti President, Global Oncology Business Unit | 52,649 0.04% of outstanding | $812k | Jul 9, 2025 | none |
| Jul 9, 2025 | Lauren Rusckowski Duprey Chief Human Resources Officer | 40,919 0.03% of outstanding | $631k | Jul 9, 2025 | none |
Transactions
The newest 50 of 81 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Lauren Rusckowski Duprey Chief Transformation Officer | SOpen-market sale American Depositary Shares | -34,535 | $18.54 | $640k | 191,522 | 28 d ago |
| Sep 2, 2026 | Andrew Stewart Plump President, R&D | SOpen-market sale American Depositary Sharesindirect: By Trust10b5-1 | -116,191 | $18.49 | $2.1M | 145,465 | 40 d ago |
| Aug 19, 2026 | Andrew Stewart Plump President, R&D | SOpen-market sale American Depositary Sharesindirect: By Trust10b5-1 | -19,651 | $18.49 | $363k | 261,656 | Aug 21, 2026 |
| Aug 18, 2026 | Nicola Deidre Petal Greenway Chief Human Resources Officer | SOpen-market sale American Depositary Shares | -12,980 | $18.11 | $235k | 40,049 | Aug 19, 2026 |
| Aug 10, 2026 | Andrew Stewart Plump President, R&D | SOpen-market sale American Depositary Shares | -165,393 | $17.10 | $2.8M | 766,569 | Aug 12, 2026 |
| Aug 10, 2026 | Natalie Anne Marie Furney Global General Counsel | SOpen-market sale American Depositary Shares | -30,868 | $17.10 | $528k | 204,298 | Aug 12, 2026 |
| Aug 10, 2026 | Lauren Rusckowski Duprey Chief Transformation Officer | SOpen-market sale American Depositary Shares | -47,586 | $17.10 | $814k | 226,057 | Aug 12, 2026 |
| Aug 10, 2026 | Agosti Marcello Pignagnoli Head, Strat. & Port. Dev | SOpen-market sale American Depositary Shares | -22,957 | $17.10 | $393k | 176,977 | Aug 12, 2026 |
| Aug 11, 2026 | Elaine Mary Shannon Pres., Global Supply & Quality | SOpen-market sale American Depositary Shares | -20,363 | $17.55 | $357k | 67,311 | Aug 12, 2026 |
| Aug 10, 2026 | Awny Samaan Botros Farajallah Chief Medical Officer | SOpen-market sale American Depositary Shares | -14,006 | $17.10 | $240k | 116,177 | Aug 12, 2026 |
| Aug 10, 2026 | Gabriele Ricci Chief Data & Tech. Officer | SOpen-market sale American Depositary Shares | -25,088 | $17.10 | $429k | 171,654 | Aug 12, 2026 |
| Aug 10, 2026 | Elaine Mary Shannon Pres., Global Supply & Quality | SOpen-market sale American Depositary Shares | -3,978 | $17.10 | $68k | 63,333 | Aug 12, 2026 |
| Aug 10, 2026 | Ramy Riad Ahmed Ibrahim President, PDT BU | SOpen-market sale American Depositary Shares | -7,277 | $17.10 | $124k | 102,588 | Aug 12, 2026 |
| Aug 10, 2026 | Nicola Deidre Petal Greenway Chief Human Resources Officer | SOpen-market sale American Depositary Shares | -975 | $17.50 | $17k | 93,431 | Aug 12, 2026 |
| Aug 10, 2026 | Julie So-Young Kim President and CEO | SOpen-market sale American Depositary Shares | -89,090 | $17.10 | $1.5M | 391,489 | Aug 12, 2026 |
| Aug 10, 2026 | Giles Richard Platford President, IBU | SOpen-market sale American Depositary Shares | -31,083 | $17.10 | $532k | 315,838 | Aug 12, 2026 |
| Aug 10, 2026 | Nicola Deidre Petal Greenway Chief Human Resources Officer | SOpen-market sale American Depositary Shares | -6,774 | $17.10 | $116k | 53,029 | Aug 12, 2026 |
| Aug 10, 2026 | Teresa Marie Bitetti President, OBU | SOpen-market sale American Depositary Shares | -50,012 | $17.10 | $855k | 252,010 | Aug 12, 2026 |
| Aug 10, 2026 | Rhonda Janice Pacheco President, U.S. Business Unit | SOpen-market sale American Depositary Shares | -16,901 | $17.10 | $289k | 182,507 | Aug 12, 2026 |
| Aug 10, 2026 | Nicola Deidre Petal Greenway Chief Human Resources Officer | SOpen-market sale American Depositary Shares | -33,628 | $17.51 | $589k | 59,803 | Aug 12, 2026 |
| Jul 1, 2026 | Natalie Anne Marie Furney Global General Counsel | AGrant or award American Depositary Shares | +43,886 | $0.00 | $0 | 235,166 | Jul 6, 2026 |
| Jul 1, 2026 | Asuka Miyabashira President, Japan Pharma B.U. | AGrant or award Ordinary Shares | +1,500 | $0.00 | $0 | 4,500 | Jul 6, 2026 |
| Jul 1, 2026 | Milano Furuta Chief Financial Officer | AGrant or award Ordinary Shares | +12,300 | $0.00 | $0 | 70,200 | Jul 6, 2026 |
| Jul 1, 2026 | Gabriele Ricci Chief Data & Tech. Officer | AGrant or award American Depositary Shares | +37,616 | $0.00 | $0 | 196,742 | Jul 6, 2026 |
| Jul 1, 2026 | John Maraganore director | AGrant or award Ordinary Shares | +3,800 | $0.00 | $0 | 10,400 | Jul 6, 2026 |
| Jul 1, 2026 | Steven Gillis director | AGrant or award Ordinary Shares | +3,800 | $0.00 | $0 | 10,400 | Jul 6, 2026 |
| Jul 1, 2026 | Awny Samaan Botros Farajallah Chief Medical Officer | AGrant or award American Depositary Shares | +17,554 | $0.00 | $0 | 130,183 | Jul 6, 2026 |
| Jul 1, 2026 | Ramy Riad Ahmed Ibrahim President, PDT BU | AGrant or award American Depositary Shares | +25,078 | $0.00 | $0 | 109,865 | Jul 6, 2026 |
| Jul 1, 2026 | Andrew Stewart Plump President, R&D | AGrant or award American Depositary Shares | +125,390 | $0.00 | $0 | 931,962 | Jul 6, 2026 |
| Jul 1, 2026 | Masami Iijima director | AGrant or award Ordinary Shares | +1,800 | $0.00 | $0 | 14,601 | Jul 6, 2026 |
| Jul 1, 2026 | Elaine Mary Shannon Pres., Global Supply & Quality | AGrant or award American Depositary Shares | +30,094 | $0.00 | $0 | 87,674 | Jul 6, 2026 |
| Jul 1, 2026 | Julie So-Young Kim President and CEO | AGrant or award American Depositary Shares | +50,434 | $0.00 | $0 | 480,579 | Jul 6, 2026 |
| Jul 1, 2026 | Kimberly A. Reed director | AGrant or award Ordinary Shares | +3,800 | $0.00 | $0 | 10,400 | Jul 6, 2026 |
| Jul 1, 2026 | Koichiro Kimura director | AGrant or award Ordinary Shares | +1,800 | $0.00 | $0 | 1,800 | Jul 6, 2026 |
| Jul 1, 2026 | Nicola Deidre Petal Greenway Chief Human Resources Officer | AGrant or award American Depositary Shares | +22,570 | $0.00 | $0 | 94,406 | Jul 6, 2026 |
| Jul 1, 2026 | Jennifer Marie Smoter Chief Comm. & Gov. Officer | AGrant or award American Depositary Shares | +18,808 | $0.00 | $0 | 18,808 | Jul 6, 2026 |
| Jul 1, 2026 | Rhonda Janice Pacheco President, U.S. Business Unit | AGrant or award American Depositary Shares | +50,156 | $0.00 | $0 | 199,408 | Jul 6, 2026 |
| Jul 1, 2026 | Paulus Stoffels director | AGrant or award Ordinary Shares | +3,800 | $0.00 | $0 | 3,800 | Jul 6, 2026 |
| Jul 1, 2026 | Agosti Marcello Pignagnoli Head, Strat. & Port. Dev. | AGrant or award American Depositary Shares | +27,586 | $0.00 | $0 | 199,934 | Jul 6, 2026 |
| Jul 1, 2026 | Bruce D Broussard director | AGrant or award American Depositary Shares | +3,800 | $0.00 | $0 | 4,595 | Jul 6, 2026 |
| Jul 1, 2026 | Miki Tsusaka director | AGrant or award Ordinary Shares | +1,800 | $0.00 | $0 | 8,200 | Jul 6, 2026 |
| Jul 1, 2026 | Giles Richard Platford President, IBU | AGrant or award American Depositary Shares | +49,558 | $0.00 | $0 | 346,921 | Jul 6, 2026 |
| Jul 1, 2026 | Teresa Marie Bitetti President, OBU | AGrant or award American Depositary Shares | +43,886 | $0.00 | $0 | 302,022 | Jul 6, 2026 |
| Jul 1, 2026 | Lauren Rusckowski Duprey Chief Transformation Officer | AGrant or award American Depositary Shares | +45,140 | $0.00 | $0 | 273,643 | Jul 6, 2026 |
| Jul 10, 2026 | Milano Furuta Chief Financial Officer | DDisposition to issuer Tax Obligation Awardderivative | -16,619 | $4,931.50 | $82M | 0 | Jul 6, 2026 |
| Jul 1, 2026 | Julie So-Young Kim President and CEO | AGrant or award Ordinary Shares | +22,800 | $0.00 | $0 | 22,800 | Jul 6, 2026 |
| Jul 10, 2026 | Asuka Miyabashira President, Japan Pharma B.U. | DDisposition to issuer Tax Obligation Awardderivative | -1,022 | $4,931.40 | $5.0M | 0 | Jul 6, 2026 |
| Jul 10, 2026 | Masami Iijima director | DDisposition to issuer Tax Obligation Awardderivative | -2,152 | $4,931.20 | $11M | 0 | Jul 6, 2026 |
| Jul 1, 2026 | Koichiro Kimura director | AGrant or award Tax Obligation Awardderivative | +1,937 | $0.00 | $0 | 1,937 | Jul 6, 2026 |
| Jul 10, 2026 | Miki Tsusaka director | DDisposition to issuer Tax Obligation Awardderivative | -2,152 | $4,931.20 | $11M | 0 | Jul 6, 2026 |
50 of 81 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Bruce D Broussarddirector, ceo, officer
- Teresa Marie BitettiPresident, OBU
- Lauren Rusckowski DupreyChief Transformation Officer
- Awny Samaan Botros FarajallahChief Medical Officer
- Natalie Anne Marie FurneyGlobal General Counsel
- Milano FurutaChief Financial Officer
- Steven Gillisowner, director
- Nicola Deidre Petal GreenwayChief Human Resources Officer
- Ramy Riad Ahmed IbrahimPresident, PDT BU
- Masami Iijimadirector
- Julie So-Young KimPresident and CEO
- Koichiro Kimuradirector
- John Maraganoredirector
- Asuka MiyabashiraPresident, Japan Pharma B.U.
- Rhonda Janice PachecoPresident, U.S. Business Unit
- Agosti Marcello PignagnoliHead, Strat. & Port. Dev
- Giles Richard PlatfordPresident, IBU
- Andrew Stewart PlumpPresident, R&D
- Kimberly A. Reeddirector
- Gabriele RicciChief Data & Tech. Officer
- Elaine Mary ShannonPres., Global Supply & Quality
- Jennifer Marie SmoterChief Comm. & Gov. Officer
- Paulus Stoffelsdirector
- Miki Tsusakadirector
Questions about TAK
Answered from the filings on this page, as of the latest one.
Are insiders buying TAK?
As of Sep 15, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 19 open-market sells worth $13M by 13 insiders at TAKEDA PHARMACEUTICAL CO LTD in the last 90 days, net -$13M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade TAK on the open market?
Lauren Rusckowski Duprey (Chief Transformation Officer) sold $640k of TAK on Sep 14, 2026 and filed the Form 4 on Sep 15, 2026. InsiderTell scored 48 (moderate), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at TAKEDA PHARMACEUTICAL CO LTD?
24 people have filed a Form 4 at TAKEDA PHARMACEUTICAL CO LTD, among them Bruce D Broussard (director and CEO), Teresa Marie Bitetti (President, OBU), Lauren Rusckowski Duprey (Chief Transformation Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.